 | • レポートコード：GIR-107A14315 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腎臓移植拒絶治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腎臓移植拒絶治療の種類別市場規模（アザチオプリン、コルチナ、シクロホスファミド、シクロスポリンA、その他）、用途別市場規模（病院、クリニック、ASC、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腎臓移植拒絶治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：CSL Limited、Digna Biotech, S.L.、GlaxoSmithKline Plc、Grifols, S.A.、Hansa Medical AB、Kyowa Hakko Kirin、Mabtech Limited、Magnus Life Ltd、Noorik Biopharmaceuticals AG、Novartis AG、Opsona Therapeutics Limited、OSE Immunotherapeutics、Pharmicell、Pharming Group N.V. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アザチオプリン、コルチナ、シクロホスファミド、シクロスポリンA、その他 ・用途別分析2016年-2026年：病院、クリニック、ASC、その他 ・腎臓移植拒絶治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腎臓移植拒絶治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腎臓移植拒絶治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腎臓移植拒絶治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腎臓移植拒絶治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Kidney Transplant Rejection Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Kidney Transplant Rejection Therapeutics size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Kidney Transplant Rejection Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Kidney Transplant Rejection Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Azathioprine
Cortina
Cyclophosphamide
Cyclosporin A
Other
Market segment by Application can be divided into
Hospital
Clinic
ASCs
Others
The key market players for global Kidney Transplant Rejection Therapeutics market are listed below:
CSL Limited
Digna Biotech, S.L.
GlaxoSmithKline Plc
Grifols, S.A.
Hansa Medical AB
Kyowa Hakko Kirin
Mabtech Limited
Magnus Life Ltd
Noorik Biopharmaceuticals AG
Novartis AG
Opsona Therapeutics Limited
OSE Immunotherapeutics
Pharmicell
Pharming Group N.V.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Kidney Transplant Rejection Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney Transplant Rejection Therapeutics, with price, sales, revenue and global market share of Kidney Transplant Rejection Therapeutics from 2019 to 2021.
Chapter 3, the Kidney Transplant Rejection Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney Transplant Rejection Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Kidney Transplant Rejection Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Kidney Transplant Rejection Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Kidney Transplant Rejection Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Transplant Rejection Therapeutics Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Azathioprine
1.2.3 Cortina
1.2.4 Cyclophosphamide
1.2.5 Cyclosporin A
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Transplant Rejection Therapeutics Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.3.5 Others
1.4 Global Kidney Transplant Rejection Therapeutics Market Size & Forecast
1.4.1 Global Kidney Transplant Rejection Therapeutics Sales in Value (2016-2026))
1.4.2 Global Kidney Transplant Rejection Therapeutics Sales in Volume (2016-2026)
1.4.3 Global Kidney Transplant Rejection Therapeutics Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Kidney Transplant Rejection Therapeutics Production Capacity Analysis
1.5.1 Global Kidney Transplant Rejection Therapeutics Total Production Capacity (2016-2026)
1.5.2 Global Kidney Transplant Rejection Therapeutics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney Transplant Rejection Therapeutics Market Drivers
1.6.2 Kidney Transplant Rejection Therapeutics Market Restraints
1.6.3 Kidney Transplant Rejection Therapeutics Trends Analysis
2 Manufacturers Profiles
2.1 CSL Limited
2.1.1 CSL Limited Details
2.1.2 CSL Limited Major Business
2.1.3 CSL Limited Kidney Transplant Rejection Therapeutics Product and Services
2.1.4 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Digna Biotech, S.L.
2.2.1 Digna Biotech, S.L. Details
2.2.2 Digna Biotech, S.L. Major Business
2.2.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product and Services
2.2.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GlaxoSmithKline Plc
2.3.1 GlaxoSmithKline Plc Details
2.3.2 GlaxoSmithKline Plc Major Business
2.3.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product and Services
2.3.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Grifols, S.A.
2.4.1 Grifols, S.A. Details
2.4.2 Grifols, S.A. Major Business
2.4.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Product and Services
2.4.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Hansa Medical AB
2.5.1 Hansa Medical AB Details
2.5.2 Hansa Medical AB Major Business
2.5.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Product and Services
2.5.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Kyowa Hakko Kirin
2.6.1 Kyowa Hakko Kirin Details
2.6.2 Kyowa Hakko Kirin Major Business
2.6.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product and Services
2.6.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Mabtech Limited
2.7.1 Mabtech Limited Details
2.7.2 Mabtech Limited Major Business
2.7.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Product and Services
2.7.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Magnus Life Ltd
2.8.1 Magnus Life Ltd Details
2.8.2 Magnus Life Ltd Major Business
2.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product and Services
2.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Noorik Biopharmaceuticals AG
2.9.1 Noorik Biopharmaceuticals AG Details
2.9.2 Noorik Biopharmaceuticals AG Major Business
2.9.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product and Services
2.9.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Novartis AG
2.10.1 Novartis AG Details
2.10.2 Novartis AG Major Business
2.10.3 Novartis AG Kidney Transplant Rejection Therapeutics Product and Services
2.10.4 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Opsona Therapeutics Limited
2.11.1 Opsona Therapeutics Limited Details
2.11.2 Opsona Therapeutics Limited Major Business
2.11.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product and Services
2.11.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 OSE Immunotherapeutics
2.12.1 OSE Immunotherapeutics Details
2.12.2 OSE Immunotherapeutics Major Business
2.12.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product and Services
2.12.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Pharmicell
2.13.1 Pharmicell Details
2.13.2 Pharmicell Major Business
2.13.3 Pharmicell Kidney Transplant Rejection Therapeutics Product and Services
2.13.4 Pharmicell Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Pharming Group N.V.
2.14.1 Pharming Group N.V. Details
2.14.2 Pharming Group N.V. Major Business
2.14.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product and Services
2.14.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Kidney Transplant Rejection Therapeutics Sales by Manufacturer
3.1 Global Kidney Transplant Rejection Therapeutics Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Kidney Transplant Rejection Therapeutics
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney Transplant Rejection Therapeutics Manufacturer Market Share
3.4.2 Top 6 Kidney Transplant Rejection Therapeutics Manufacturer Market Share
3.5 Global Kidney Transplant Rejection Therapeutics Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Kidney Transplant Rejection Therapeutics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney Transplant Rejection Therapeutics Market Size by Region
4.1.1 Global Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2016-2026)
4.1.2 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2016-2026)
4.2 North America Kidney Transplant Rejection Therapeutics Revenue (2016-2026)
4.3 Europe Kidney Transplant Rejection Therapeutics Revenue (2016-2026)
4.4 Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue (2016-2026)
4.5 South America Kidney Transplant Rejection Therapeutics Revenue (2016-2026)
4.6 Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Kidney Transplant Rejection Therapeutics Sales in Volume by Type (2016-2026)
5.2 Global Kidney Transplant Rejection Therapeutics Revenue by Type (2016-2026)
5.3 Global Kidney Transplant Rejection Therapeutics Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Kidney Transplant Rejection Therapeutics Sales in Volume by Application (2016-2026)
6.2 Global Kidney Transplant Rejection Therapeutics Revenue by Application (2016-2026)
6.3 Global Kidney Transplant Rejection Therapeutics Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Kidney Transplant Rejection Therapeutics Sales by Type (2016-2026)
7.2 North America Kidney Transplant Rejection Therapeutics Sales by Application (2016-2026)
7.3 North America Kidney Transplant Rejection Therapeutics Market Size by Country
7.3.1 North America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2016-2026)
7.3.2 North America Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney Transplant Rejection Therapeutics Sales by Type (2016-2026)
8.2 Europe Kidney Transplant Rejection Therapeutics Sales by Application (2016-2026)
8.3 Europe Kidney Transplant Rejection Therapeutics Market Size by Country
8.3.1 Europe Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2016-2026)
8.3.2 Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Type (2016-2026)
9.2 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Application (2016-2026)
9.3 Asia-Pacific Kidney Transplant Rejection Therapeutics Market Size by Region
9.3.1 Asia-Pacific Kidney Transplant Rejection Therapeutics Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Kidney Transplant Rejection Therapeutics Sales by Type (2016-2026)
10.2 South America Kidney Transplant Rejection Therapeutics Sales by Application (2016-2026)
10.3 South America Kidney Transplant Rejection Therapeutics Market Size by Country
10.3.1 South America Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2016-2026)
10.3.2 South America Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Type (2016-2026)
11.2 Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Application (2016-2026)
11.3 Middle East & Africa Kidney Transplant Rejection Therapeutics Market Size by Country
11.3.1 Middle East & Africa Kidney Transplant Rejection Therapeutics Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Kidney Transplant Rejection Therapeutics Typical Distributors
12.3 Kidney Transplant Rejection Therapeutics Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Kidney Transplant Rejection Therapeutics Revenue by Type, (USD Million), 2021-2026
Table 2. Global Kidney Transplant Rejection Therapeutics Revenue by Application, (USD Million), 2021-2026
Table 3. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 4. CSL Limited Major Business
Table 5. CSL Limited Kidney Transplant Rejection Therapeutics Product and Services
Table 6. CSL Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Digna Biotech, S.L. Basic Information, Manufacturing Base and Competitors
Table 8. Digna Biotech, S.L. Major Business
Table 9. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product and Services
Table 10. Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Plc Major Business
Table 13. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product and Services
Table 14. GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Grifols, S.A. Basic Information, Manufacturing Base and Competitors
Table 16. Grifols, S.A. Major Business
Table 17. Grifols, S.A. Kidney Transplant Rejection Therapeutics Product and Services
Table 18. Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hansa Medical AB Basic Information, Manufacturing Base and Competitors
Table 20. Hansa Medical AB Major Business
Table 21. Hansa Medical AB Kidney Transplant Rejection Therapeutics Product and Services
Table 22. Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 24. Kyowa Hakko Kirin Major Business
Table 25. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product and Services
Table 26. Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mabtech Limited Basic Information, Manufacturing Base and Competitors
Table 28. Mabtech Limited Major Business
Table 29. Mabtech Limited Kidney Transplant Rejection Therapeutics Product and Services
Table 30. Mabtech Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Magnus Life Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Magnus Life Ltd Major Business
Table 33. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product and Services
Table 34. Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Noorik Biopharmaceuticals AG Basic Information, Manufacturing Base and Competitors
Table 36. Noorik Biopharmaceuticals AG Major Business
Table 37. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product and Services
Table 38. Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 40. Novartis AG Major Business
Table 41. Novartis AG Kidney Transplant Rejection Therapeutics Product and Services
Table 42. Novartis AG Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Opsona Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 44. Opsona Therapeutics Limited Major Business
Table 45. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product and Services
Table 46. Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. OSE Immunotherapeutics Basic Information, Manufacturing Base and Competitors
Table 48. OSE Immunotherapeutics Major Business
Table 49. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product and Services
Table 50. OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Pharmicell Basic Information, Manufacturing Base and Competitors
Table 52. Pharmicell Major Business
Table 53. Pharmicell Kidney Transplant Rejection Therapeutics Product and Services
Table 54. Pharmicell Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Pharming Group N.V. Basic Information, Manufacturing Base and Competitors
Table 56. Pharming Group N.V. Major Business
Table 57. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product and Services
Table 58. Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Kidney Transplant Rejection Therapeutics Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 60. Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Kidney Transplant Rejection Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Kidney Transplant Rejection Therapeutics Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 63. Head Office and Kidney Transplant Rejection Therapeutics Production Site of Key Manufacturer
Table 64. Kidney Transplant Rejection Therapeutics New Entrant and Capacity Expansion Plans
Table 65. Kidney Transplant Rejection Therapeutics Mergers & Acquisitions in the Past Five Years
Table 66. Global Kidney Transplant Rejection Therapeutics Sales by Region (2016-2021e) & (K Pcs)
Table 67. Global Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026) & (K Pcs)
Table 68. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Kidney Transplant Rejection Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 71. Global Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 72. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Kidney Transplant Rejection Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Kidney Transplant Rejection Therapeutics Price by Type (2016-2021e) & (USD/Pcs)
Table 75. Global Kidney Transplant Rejection Therapeutics Price by Type (2021-2026) & (USD/Pcs)
Table 76. Global Kidney Transplant Rejection Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 77. Global Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 78. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Kidney Transplant Rejection Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Kidney Transplant Rejection Therapeutics Price by Application (2016-2021e) & (USD/Pcs)
Table 81. Global Kidney Transplant Rejection Therapeutics Price by Application (2021-2026) & (USD/Pcs)
Table 82. North America Kidney Transplant Rejection Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 83. North America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 84. North America Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Kidney Transplant Rejection Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 87. North America Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 88. North America Kidney Transplant Rejection Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 89. North America Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 90. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 91. Europe Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 92. Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Kidney Transplant Rejection Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 95. Europe Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 96. Europe Kidney Transplant Rejection Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 97. Europe Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 98. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2021-2026) & (K Pcs)
Table 100. Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 106. South America Kidney Transplant Rejection Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 107. South America Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 108. South America Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Kidney Transplant Rejection Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 111. South America Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 112. South America Kidney Transplant Rejection Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 113. South America Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 114. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 116. Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Kidney Transplant Rejection Therapeutics Typical Distributors
Table 125. Kidney Transplant Rejection Therapeutics Typical Customers
List of Figures
Figure 1. Kidney Transplant Rejection Therapeutics Picture
Figure 2. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type in 2020
Figure 3. Azathioprine
Figure 4. Cortina
Figure 5. Cyclophosphamide
Figure 6. Cyclosporin A
Figure 7. Other
Figure 8. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application in 2020
Figure 9. Hospital
Figure 10. Clinic
Figure 11. ASCs
Figure 12. Others
Figure 13. Global Kidney Transplant Rejection Therapeutics Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Kidney Transplant Rejection Therapeutics Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Kidney Transplant Rejection Therapeutics Sales (2016-2026) & (K Pcs)
Figure 16. Global Kidney Transplant Rejection Therapeutics Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Kidney Transplant Rejection Therapeutics Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Kidney Transplant Rejection Therapeutics Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Kidney Transplant Rejection Therapeutics Market Drivers
Figure 20. Kidney Transplant Rejection Therapeutics Market Restraints
Figure 21. Kidney Transplant Rejection Therapeutics Market Trends
Figure 22. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturer in 2020
Figure 23. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Manufacturer in 2020
Figure 24. Kidney Transplant Rejection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Kidney Transplant Rejection Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Kidney Transplant Rejection Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2016-2026)
Figure 28. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2016-2026)
Figure 29. North America Kidney Transplant Rejection Therapeutics Revenue (2016-2026) & (USD Million)
Figure 30. Europe Kidney Transplant Rejection Therapeutics Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue (2016-2026) & (USD Million)
Figure 32. South America Kidney Transplant Rejection Therapeutics Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue (2016-2026) & (USD Million)
Figure 34. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2016-2026)
Figure 35. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2016-2026)
Figure 36. Global Kidney Transplant Rejection Therapeutics Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2016-2026)
Figure 38. Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2016-2026)
Figure 39. Global Kidney Transplant Rejection Therapeutics Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2016-2026)
Figure 41. North America Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2016-2026)
Figure 42. North America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2016-2026)
Figure 43. North America Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2016-2026)
Figure 50. Europe Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 51. Germany Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Kidney Transplant Rejection Therapeutics Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Kidney Transplant Rejection Therapeutics Revenue Market Share by Region (2016-2026)
Figure 60. China Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2016-2026)
Figure 67. South America Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2016-2026)
Figure 68. South America Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2016-2026)
Figure 69. South America Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Kidney Transplant Rejection Therapeutics Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Kidney Transplant Rejection Therapeutics Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Kidney Transplant Rejection Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の腎臓移植用手術器具市場 2021：企業別、地域別、種類・用途別 The Kidney Transplant Surgery Instrument market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 世界の後期慢性腎臓病治療薬市場 2021：企業別、地域別、種類・用途別 The Late Stage Chronic Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界のヒトサイトメガロウイルス65kDaリンタンパク質市場 2021：企業別、地域別、種類・用途別 The Human cytomegalovirus 65 kDa Phosphoprotein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 世界の角膜移植市場 2021：企業別、地域別、種類・用途別 The Corneal Transplant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の臓器移植用免疫抑制薬市場 2021：企業別、地域別、種類・用途別 The Organ Transplant Immunosuppressant Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…